Want to join the conversation?
$MNST said that 2Q16 results were positively impacted by the accelerated recognition of deferred revenue of $5MM and negatively impacted by the modified Dutch tender stock repurchase expenses of $1.5MM, AFF transaction costs of $3.6MM and distributor termination costs of $25.3MM. Net sales were adversely affected by unfavorable changes in FX rates.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.